Dr. Molly Shoichet, Co-Founder of AmacaThera and Professor at the University of Toronto, has been named a 2019 Distinguished Woman in Chemistry or Chemical Engineering by the International Union of Pure and Applied Chemistry (IUPAC).
Presented by Medicine by Design, in partnership with CCRM and the Rotman School of Management, this two-week workshop is an opportunity for PhD candidates and post-doctoral fellows from around the world to advance their understanding of how to translate and commercialize regenerative medicine research.
During the MaRS HealthKick Invest Conference, the MaRS HealthKick Pitch Competition will invite CEOs and executives of Canadian early-stage, investment-ready health companies to pitch to investors, C-suite leaders and industry partners.
ManagingLife's app, Manage My Pain, was featured on CTV Toronto for its collaboration with the University Health Network and pain clinics across Ontario.
The Startup Canada Awards celebrate and distinguish outstanding achievement in advancing Canadian entrepreneurship. Individuals and organizations can self-nominate or nominate someone else for an award.
OBIO’s recent Cross Border Investing panel on January 31, 2019, hosted by Osler Hoskin & Harcourt LLP and moderated by Gail Garland (CEO, OBIO), featured David Young (CEO, Kisoji Biotechnology), Mike Cooke (CEO, AmacaThera) and Chad Bayne (Partner, Osler) answering questions on their experiences raising money for Canadian companies from international investors.
Genome Canada announced a partnership with the Canadian federal government and various provincial governments, businesses, and research groups to provide C$56 million in funding for a number of bioinformatics and genomics projects.
The 2019 Johns Hopkins Healthcare Design Competition is open to all student-led teams from around the world that have designed health-related solutions.
TopSpin Technologies was named one of five finalists at the 'Innovations to Advance Athlete Health and Safety Competition,' hosted by the National Football League and Arrow Electronics, with prizes of $50,000 and two tickets to Super Bowl LIII.
FACIT and Triphase Accelerator announced a new strategic collaboration with Celgene for a first-in-class preclinical therapeutic targeting the WDR5 protein for the treatment of blood cancers including leukemia.